The slow growth of cross-product margining

Clearing houses may have promised too much, too soon on the benefits of cross-product margining, leaving them at risk of under-delivering. Only a handful of clients have so far been able to benefit – and for most, the savings have been smaller than advertised. Tom Osborn reports


Savvy consumers are wise to adverts promising huge potential benefits with no lower boundary – the cleaning agent that kills up to 100% of germs, for example, or the laptop that is up to 70% faster – but buy-side firms may need to apply the same caution when clearing houses are pushing cross-product margining services. Dealers say the eye-catching savings that appear in marketing material from CME Group and Eurex are based on cherry-picked test cases, and are proving difficult to achieve for the

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to View our subscription options

Switching CCP – How and why?

As uncertainty surrounding Brexit continues and the impacts of Covid-19-driven market volatility are analysed, it is essential for banks and their end-users to understand their clearing options, and how they can achieve greater capital and cross…

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here